Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Rev. méd. Minas Gerais ; 22(supl.5): S14-S17, 2012.
Article in Portuguese | LILACS | ID: biblio-915203

ABSTRACT

A cirurgia de controle de dano é processo de preservação do paciente politraumatizado. É concebida como método cirúrgico que surgiu com a necessidade de restaurar a fisiologia normal do paciente vítima de múltiplos traumas e o objetivo de reduzir a mortalidade relacionada ao tratamento cirúrgico definitivo. A "tríade da morte", caracterizada por hipotermia, acidose metabólica e coagulopatia, é a perturbação fisiológica temida na abordagem cirúrgica de politraumatizados. A melhora nas taxas de sobrevida após o advento da cirurgia de controle de danos, entretanto, ainda convive com taxas de mortalidade, em torno de 50%. É procedimento dispendioso e que exige preparação dos centros e equipes que irão receber esses pacientes. Dessa maneira, muitos estudos têm especulado a possibilidade de predizer a evolução de pacientes candidatos a esse tipo de intervenção, a fim de evitar a aplicação de procedimento tão dispendioso em pacientes sem chances de sobreviver. (AU)


The Damage Control Surgery is a process for the preservation of the polytraumatized patient. It was developed due to the need for restore the physiology of such patients back to their normal condition, in order to reduce the mortality rates related to the definitive surgical approach. The "triad of death" hypothermia, acidosis and coagulopathy is a major threat concerning the surgical approach for the trauma patients. Despite the improvements on the survival rates following the introduction of the Damage Control Surgery, the published data show mortality rates circa 50%. Moreover, it is a costly intervention which demands well-prepared teams and trauma centers. Thus, many studies have sought the capacity of predicting the outcome of patients candidates to this procedure, in order to avoid excessive spending with patients who have no chance of survival. (AU)


Subject(s)
Humans , Blood Coagulation Disorders/surgery , Mortality , Hypothermia/surgery , Ketosis/surgery , Survival , Blood Coagulation Disorders/physiopathology , Evaluation of Results of Therapeutic Interventions , Process Assessment, Health Care , Outcome Assessment, Health Care , Hypothermia/physiopathology , Ketosis/physiopathology
2.
Rev. bras. cir. plást ; 26(3): 538-541, July-Sept. 2011. ilus
Article in English | LILACS | ID: lil-608218

ABSTRACT

We present the case of a patient submitted to augmentation mammaplasty who developed 2 hematoma episodes as a result of von Willebrand's disease, which was not previously diagnosed. As a routine part of preoperative evaluation, the patient should always be tested for von Willebrand's disease. This disease affects 1-3 percent of the population and occurs twice as often as hemophilia. In our case, the patient recovered quite satisfactorily. Preventive and therapeutic approaches are discussed in this paper.


Os autores relatam o caso de uma paciente submetida a mamaplastia de aumento, não diagnosticada previamente como portadora de doença de von Willebrand, que teve dois episódios de hematoma no pós-operatório. Entre os distúrbios de coagulação, a doença de von Willebrand deve ser considerada na avaliação pré-operatória, pois afeta cerca de 1 por cento a 3 por cento da população, não é diagnosticada na maioria das pessoas, além de ser duas vezes mais frequente que a hemofilia. A paciente evoluiu bem no pós-operatório e medidas preventivas e terapêuticas são discutidas neste artigo.


Subject(s)
Humans , Female , Adult , History, 21st Century , Postoperative Complications , von Willebrand Diseases , Blood Coagulation Disorders , Mammaplasty , Coagulation Protein Disorders , Hematoma , Postoperative Complications/surgery , Postoperative Complications/therapy , von Willebrand Diseases/surgery , von Willebrand Diseases/pathology , von Willebrand Diseases/therapy , Blood Coagulation Disorders/surgery , Mammaplasty/adverse effects , Mammaplasty/methods , Coagulation Protein Disorders/surgery , Coagulation Protein Disorders/therapy , Hematoma/surgery , Hematoma/complications
SELECTION OF CITATIONS
SEARCH DETAIL